This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-361-5p | ABCA1 | -0.65 | 0 | -0.11 | 0.40751 | miRanda; mirMAP | -0.29 | 0.00018 | NA | |
2 | hsa-miR-361-5p | ABCB10 | -0.65 | 0 | 0.11 | 0.11119 | MirTarget; miRanda | -0.16 | 9.0E-5 | NA | |
3 | hsa-miR-361-5p | ABCD2 | -0.65 | 0 | 1.33 | 0 | miRanda | -0.7 | 0 | NA | |
4 | hsa-miR-361-5p | ABI2 | -0.65 | 0 | 0.18 | 0.00137 | miRanda | -0.17 | 0 | NA | |
5 | hsa-miR-361-5p | ABL1 | -0.65 | 0 | 0.05 | 0.42981 | miRanda | -0.1 | 0.00538 | NA | |
6 | hsa-miR-361-5p | ACACB | -0.65 | 0 | 1.1 | 0 | miRanda | -0.2 | 0.00904 | NA | |
7 | hsa-miR-361-5p | ACAP2 | -0.65 | 0 | 0.26 | 0.00083 | miRanda; mirMAP; miRNATAP | -0.24 | 0 | NA | |
8 | hsa-miR-361-5p | ACBD5 | -0.65 | 0 | -0.14 | 0.05512 | miRanda | -0.11 | 0.02033 | NA | |
9 | hsa-miR-361-5p | ACER3 | -0.65 | 0 | -0.26 | 0.08177 | mirMAP | -0.49 | 0 | NA | |
10 | hsa-miR-361-5p | ACSL6 | -0.65 | 0 | 1.58 | 0 | miRanda | -0.62 | 0 | NA | |
11 | hsa-miR-361-5p | ACTC1 | -0.65 | 0 | 3.4 | 0 | miRanda; miRNATAP | -0.85 | 0.00022 | NA | |
12 | hsa-miR-361-5p | ACTN4 | -0.65 | 0 | 0.43 | 0 | miRanda | -0.2 | 0 | NA | |
13 | hsa-miR-361-5p | ADAM10 | -0.65 | 0 | 0.28 | 0.07197 | miRanda | -0.56 | 0 | NA | |
14 | hsa-miR-361-5p | ADAM19 | -0.65 | 0 | 0.86 | 0 | miRanda | -0.27 | 0.00381 | NA | |
15 | hsa-miR-361-5p | ADAM22 | -0.65 | 0 | 1.06 | 1.0E-5 | mirMAP | -0.77 | 0 | NA | |
16 | hsa-miR-361-5p | ADAM28 | -0.65 | 0 | 1.23 | 0 | mirMAP | -0.6 | 0 | NA | |
17 | hsa-miR-361-5p | ADAMTS5 | -0.65 | 0 | 1.91 | 0 | PITA; miRanda | -0.78 | 0 | NA | |
18 | hsa-miR-361-5p | ADCY9 | -0.65 | 0 | 0.73 | 0 | miRanda | -0.36 | 0 | NA | |
19 | hsa-miR-361-5p | ADD3 | -0.65 | 0 | 0.99 | 0 | MirTarget; PITA; miRanda; miRNATAP | -0.36 | 6.0E-5 | NA | |
20 | hsa-miR-361-5p | ADNP | -0.65 | 0 | -0.03 | 0.67622 | miRanda | -0.14 | 0.00429 | NA | |
21 | hsa-miR-361-5p | ADSS | -0.65 | 0 | 0.05 | 0.42961 | miRanda | -0.19 | 0 | NA | |
22 | hsa-miR-361-5p | AEBP2 | -0.65 | 0 | 0.32 | 0 | MirTarget; PITA; miRanda | -0.14 | 8.0E-5 | NA | |
23 | hsa-miR-361-5p | AFF2 | -0.65 | 0 | 1.9 | 0 | PITA; mirMAP | -0.71 | 0 | NA | |
24 | hsa-miR-361-5p | AFF4 | -0.65 | 0 | 0.21 | 0.01507 | miRanda | -0.28 | 0 | NA | |
25 | hsa-miR-361-5p | AGL | -0.65 | 0 | 0.51 | 0 | miRanda | -0.33 | 0 | NA | |
26 | hsa-miR-361-5p | AGPS | -0.65 | 0 | 0.88 | 0 | miRanda; miRNATAP | -0.41 | 0 | NA | |
27 | hsa-miR-361-5p | AGR2 | -0.65 | 0 | -0.57 | 0.01438 | miRanda | -0.29 | 0.04234 | NA | |
28 | hsa-miR-361-5p | AHCYL2 | -0.65 | 0 | 0.09 | 0.27752 | miRanda | -0.17 | 0.00095 | NA | |
29 | hsa-miR-361-5p | AHNAK | -0.65 | 0 | 0.45 | 5.0E-5 | miRanda | -0.41 | 0 | NA | |
30 | hsa-miR-361-5p | AJAP1 | -0.65 | 0 | 1.01 | 0 | miRanda | -0.44 | 0.00076 | NA | |
31 | hsa-miR-361-5p | AK3 | -0.65 | 0 | 0.2 | 0.00026 | miRanda | -0.1 | 0.00174 | NA | |
32 | hsa-miR-361-5p | AKAP11 | -0.65 | 0 | 0.67 | 0 | mirMAP | -0.39 | 0 | NA | |
33 | hsa-miR-361-5p | AKAP5 | -0.65 | 0 | -0.19 | 0.15744 | miRanda | -0.21 | 0.01316 | NA | |
34 | hsa-miR-361-5p | AKAP6 | -0.65 | 0 | 0.91 | 0 | miRanda | -0.3 | 0.0008 | NA | |
35 | hsa-miR-361-5p | ALDH1L2 | -0.65 | 0 | 1.86 | 0 | miRanda; mirMAP; miRNATAP | -0.69 | 0 | NA | |
36 | hsa-miR-361-5p | ALDH6A1 | -0.65 | 0 | -0.22 | 0.08256 | miRanda; miRNATAP | -0.2 | 0.00876 | NA | |
37 | hsa-miR-361-5p | AMBRA1 | -0.65 | 0 | 0.04 | 0.36283 | miRanda | -0.12 | 2.0E-5 | NA | |
38 | hsa-miR-361-5p | AMFR | -0.65 | 0 | 0.31 | 0 | miRanda | -0.16 | 0 | NA | |
39 | hsa-miR-361-5p | AMIGO2 | -0.65 | 0 | 0.96 | 0 | miRanda | -0.34 | 0.00071 | NA | |
40 | hsa-miR-361-5p | ANGPT1 | -0.65 | 0 | 2.4 | 0 | miRanda | -0.8 | 0 | NA | |
41 | hsa-miR-361-5p | ANGPTL2 | -0.65 | 0 | 0.68 | 0 | miRanda | -0.37 | 3.0E-5 | NA | |
42 | hsa-miR-361-5p | ANKFY1 | -0.65 | 0 | 0.17 | 0.00776 | miRanda | -0.22 | 0 | NA | |
43 | hsa-miR-361-5p | ANKRD12 | -0.65 | 0 | 0.3 | 0.00012 | miRanda | -0.23 | 0 | NA | |
44 | hsa-miR-361-5p | ANKRD17 | -0.65 | 0 | 0.05 | 0.56613 | miRanda | -0.29 | 0 | NA | |
45 | hsa-miR-361-5p | ANKRD34B | -0.65 | 0 | -2.97 | 0 | MirTarget; miRanda | -0.66 | 0.03915 | NA | |
46 | hsa-miR-361-5p | ANKRD42 | -0.65 | 0 | 0.28 | 0 | miRanda | -0.12 | 0.0001 | NA | |
47 | hsa-miR-361-5p | ANKRD44 | -0.65 | 0 | 0.89 | 0 | miRanda | -0.57 | 0 | NA | |
48 | hsa-miR-361-5p | ANO1 | -0.65 | 0 | 1.77 | 0 | miRanda; miRNATAP | -0.71 | 0 | NA | |
49 | hsa-miR-361-5p | ANO3 | -0.65 | 0 | 0.1 | 0.73748 | miRanda | -0.37 | 0.03443 | NA | |
50 | hsa-miR-361-5p | ANO6 | -0.65 | 0 | 1.4 | 0 | MirTarget; miRanda | -0.49 | 0 | NA | |
51 | hsa-miR-361-5p | AOC3 | -0.65 | 0 | 1.08 | 0 | MirTarget; miRanda | -0.34 | 0.00059 | NA | |
52 | hsa-miR-361-5p | AP1S2 | -0.65 | 0 | 0.58 | 0 | miRanda | -0.2 | 0.0005 | NA | |
53 | hsa-miR-361-5p | AP1S3 | -0.65 | 0 | -0.01 | 0.95392 | miRanda | -0.29 | 1.0E-5 | NA | |
54 | hsa-miR-361-5p | AP3B1 | -0.65 | 0 | 0.22 | 0.00076 | miRanda | -0.26 | 0 | NA | |
55 | hsa-miR-361-5p | APH1B | -0.65 | 0 | -0.03 | 0.73374 | miRanda | -0.15 | 0.00134 | NA | |
56 | hsa-miR-361-5p | APPBP2 | -0.65 | 0 | 0.1 | 0.10538 | PITA; miRanda | -0.23 | 0 | NA | |
57 | hsa-miR-361-5p | AQP9 | -0.65 | 0 | 1.39 | 0 | miRanda | -0.65 | 0 | NA | |
58 | hsa-miR-361-5p | AR | -0.65 | 0 | 0.44 | 0.04112 | mirMAP | -0.52 | 6.0E-5 | NA | |
59 | hsa-miR-361-5p | ARCN1 | -0.65 | 0 | 0.03 | 0.63018 | miRNAWalker2 validate; PITA; miRanda; miRNATAP | -0.15 | 1.0E-5 | NA | |
60 | hsa-miR-361-5p | ARF4 | -0.65 | 0 | -0.14 | 0.02364 | miRNAWalker2 validate; miRanda | -0.1 | 0.00614 | NA | |
61 | hsa-miR-361-5p | ARFGEF2 | -0.65 | 0 | 0.32 | 0.00076 | miRanda | -0.35 | 0 | NA | |
62 | hsa-miR-361-5p | ARHGAP20 | -0.65 | 0 | 1.96 | 0 | miRanda | -0.82 | 0 | NA | |
63 | hsa-miR-361-5p | ARHGAP21 | -0.65 | 0 | 0.16 | 0.02238 | miRanda | -0.22 | 0 | NA | |
64 | hsa-miR-361-5p | ARHGAP31 | -0.65 | 0 | 0.55 | 0 | mirMAP | -0.41 | 0 | NA | |
65 | hsa-miR-361-5p | ARHGAP42 | -0.65 | 0 | 0.38 | 0.00337 | miRanda | -0.32 | 4.0E-5 | NA | |
66 | hsa-miR-361-5p | ARHGEF12 | -0.65 | 0 | 0.23 | 0.00506 | miRNATAP | -0.3 | 0 | NA | |
67 | hsa-miR-361-5p | ARHGEF6 | -0.65 | 0 | 0.49 | 1.0E-5 | miRanda | -0.23 | 0.00054 | NA | |
68 | hsa-miR-361-5p | ARHGEF9 | -0.65 | 0 | 0.61 | 0 | miRanda | -0.18 | 4.0E-5 | NA | |
69 | hsa-miR-361-5p | ARID1A | -0.65 | 0 | -0.13 | 0.09882 | miRanda | -0.13 | 0.00542 | NA | |
70 | hsa-miR-361-5p | ARID2 | -0.65 | 0 | 0.15 | 0.02675 | MirTarget; PITA; miRanda | -0.22 | 0 | NA | |
71 | hsa-miR-361-5p | ARID4A | -0.65 | 0 | 0.39 | 0 | miRanda | -0.23 | 0 | NA | |
72 | hsa-miR-361-5p | ARIH1 | -0.65 | 0 | 0.12 | 0.01391 | miRanda | -0.19 | 0 | NA | |
73 | hsa-miR-361-5p | ARL1 | -0.65 | 0 | 0.12 | 0.02491 | miRanda | -0.18 | 0 | NA | |
74 | hsa-miR-361-5p | ARL10 | -0.65 | 0 | 1.23 | 0 | mirMAP | -0.44 | 1.0E-5 | NA | |
75 | hsa-miR-361-5p | ARL13B | -0.65 | 0 | 0.07 | 0.44506 | miRanda | -0.2 | 0.00027 | NA | |
76 | hsa-miR-361-5p | ARL4C | -0.65 | 0 | 0.78 | 0 | miRanda | -0.24 | 0.00095 | NA | |
77 | hsa-miR-361-5p | ARMC8 | -0.65 | 0 | 0.23 | 1.0E-5 | PITA; miRanda; miRNATAP | -0.14 | 1.0E-5 | NA | |
78 | hsa-miR-361-5p | ARNT | -0.65 | 0 | 0.21 | 3.0E-5 | miRanda | -0.18 | 0 | NA | |
79 | hsa-miR-361-5p | ARNTL | -0.65 | 0 | 0.59 | 0 | miRanda | -0.17 | 0.006 | NA | |
80 | hsa-miR-361-5p | ARRDC3 | -0.65 | 0 | 0.49 | 2.0E-5 | MirTarget; PITA; miRanda; miRNATAP | -0.35 | 0 | NA | |
81 | hsa-miR-361-5p | ARSB | -0.65 | 0 | 0.32 | 0.00016 | miRanda | -0.41 | 0 | NA | |
82 | hsa-miR-361-5p | ASAP2 | -0.65 | 0 | 0.12 | 0.1751 | miRanda | -0.27 | 0 | NA | |
83 | hsa-miR-361-5p | ASB7 | -0.65 | 0 | 0.11 | 0.02221 | miRanda | -0.13 | 1.0E-5 | NA | |
84 | hsa-miR-361-5p | ASCC3 | -0.65 | 0 | 0.35 | 0.00431 | miRanda | -0.41 | 0 | NA | |
85 | hsa-miR-361-5p | ASF1A | -0.65 | 0 | 0.22 | 0.01618 | miRanda | -0.12 | 0.02969 | NA | |
86 | hsa-miR-361-5p | ASH1L | -0.65 | 0 | 0.37 | 0.0002 | miRNAWalker2 validate | -0.37 | 0 | NA | |
87 | hsa-miR-361-5p | ASPH | -0.65 | 0 | 1.11 | 0 | miRanda | -0.47 | 0 | NA | |
88 | hsa-miR-361-5p | ASTN1 | -0.65 | 0 | 2.02 | 0 | miRanda | -0.62 | 0.00073 | NA | |
89 | hsa-miR-361-5p | ASXL3 | -0.65 | 0 | 1.72 | 0 | mirMAP | -0.55 | 2.0E-5 | NA | |
90 | hsa-miR-361-5p | ATF2 | -0.65 | 0 | 0.55 | 4.0E-5 | miRanda | -0.52 | 0 | NA | |
91 | hsa-miR-361-5p | ATF3 | -0.65 | 0 | 1.01 | 0.00012 | miRanda | -0.37 | 0.02168 | NA | |
92 | hsa-miR-361-5p | ATF7 | -0.65 | 0 | 0.07 | 0.28145 | mirMAP | -0.25 | 0 | NA | |
93 | hsa-miR-361-5p | ATG5 | -0.65 | 0 | 0.45 | 0 | miRanda | -0.19 | 0.00158 | NA | |
94 | hsa-miR-361-5p | ATL2 | -0.65 | 0 | 0.4 | 0 | miRanda | -0.21 | 0 | NA | |
95 | hsa-miR-361-5p | ATL3 | -0.65 | 0 | 0.24 | 0.02942 | mirMAP | -0.35 | 0 | NA | |
96 | hsa-miR-361-5p | ATP6V1A | -0.65 | 0 | -0.09 | 0.21178 | miRNAWalker2 validate | -0.15 | 0.00035 | NA | |
97 | hsa-miR-361-5p | ATP7A | -0.65 | 0 | 0.12 | 0.16166 | miRanda | -0.21 | 8.0E-5 | NA | |
98 | hsa-miR-361-5p | ATP9A | -0.65 | 0 | 0.16 | 0.03136 | miRanda | -0.32 | 0 | NA | |
99 | hsa-miR-361-5p | ATR | -0.65 | 0 | -0.26 | 0.00138 | miRanda | -0.12 | 0.01466 | NA | |
100 | hsa-miR-361-5p | ATRNL1 | -0.65 | 0 | 1.7 | 0 | miRanda | -0.45 | 0.00089 | NA | |
101 | hsa-miR-361-5p | ATXN1L | -0.65 | 0 | 0.43 | 0 | miRanda | -0.33 | 0 | NA | |
102 | hsa-miR-361-5p | AVL9 | -0.65 | 0 | -0.23 | 0.04984 | miRanda | -0.23 | 0.00113 | NA | |
103 | hsa-miR-361-5p | AXL | -0.65 | 0 | 0.75 | 0 | miRanda | -0.29 | 0.00014 | NA | |
104 | hsa-miR-361-5p | B2M | -0.65 | 0 | 0.2 | 0.04836 | miRanda | -0.13 | 0.0376 | NA | |
105 | hsa-miR-361-5p | B3GALNT1 | -0.65 | 0 | 0.56 | 5.0E-5 | miRanda | -0.52 | 0 | NA | |
106 | hsa-miR-361-5p | B4GALT6 | -0.65 | 0 | 0.82 | 0 | MirTarget; miRanda | -0.33 | 0 | NA | |
107 | hsa-miR-361-5p | BACH1 | -0.65 | 0 | -0.18 | 0.04671 | miRanda; mirMAP | -0.17 | 0.00187 | NA | |
108 | hsa-miR-361-5p | BAZ2B | -0.65 | 0 | 0.33 | 2.0E-5 | miRanda | -0.19 | 3.0E-5 | NA | |
109 | hsa-miR-361-5p | BBS10 | -0.65 | 0 | 0.3 | 0.00018 | miRanda | -0.25 | 0 | NA | |
110 | hsa-miR-361-5p | BBX | -0.65 | 0 | 0.86 | 0 | PITA; miRanda; mirMAP | -0.47 | 0 | NA | |
111 | hsa-miR-361-5p | BCOR | -0.65 | 0 | -0.28 | 0.00771 | miRanda | -0.23 | 0.00036 | NA | |
112 | hsa-miR-361-5p | BCORL1 | -0.65 | 0 | 0.26 | 0.00303 | MirTarget; PITA; miRanda; miRNATAP | -0.3 | 0 | NA | |
113 | hsa-miR-361-5p | BDNF | -0.65 | 0 | 1.66 | 0 | PITA; miRanda; miRNATAP | -0.47 | 0.00023 | NA | |
114 | hsa-miR-361-5p | BDP1 | -0.65 | 0 | 0.16 | 0.12278 | miRanda; mirMAP | -0.24 | 0.00014 | NA | |
115 | hsa-miR-361-5p | BEND7 | -0.65 | 0 | 0.36 | 0.00534 | mirMAP | -0.43 | 0 | NA | |
116 | hsa-miR-361-5p | BLZF1 | -0.65 | 0 | 0.38 | 0 | miRanda | -0.25 | 0 | NA | |
117 | hsa-miR-361-5p | BMP2K | -0.65 | 0 | 0.18 | 0.09946 | miRanda | -0.3 | 0 | NA | |
118 | hsa-miR-361-5p | BMP3 | -0.65 | 0 | 0.66 | 0.018 | miRanda; mirMAP | -0.5 | 0.00306 | NA | |
119 | hsa-miR-361-5p | BMP7 | -0.65 | 0 | 1.55 | 0 | miRanda | -0.65 | 2.0E-5 | NA | |
120 | hsa-miR-361-5p | BMPR2 | -0.65 | 0 | 0.33 | 8.0E-5 | MirTarget; miRanda; mirMAP; miRNATAP | -0.35 | 0 | NA | |
121 | hsa-miR-361-5p | BNIP3L | -0.65 | 0 | 0.75 | 0 | PITA; miRanda | -0.43 | 0 | NA | |
122 | hsa-miR-361-5p | BRIP1 | -0.65 | 0 | 0.08 | 0.67378 | miRanda | -0.26 | 0.02267 | NA | |
123 | hsa-miR-361-5p | BRPF3 | -0.65 | 0 | 0.06 | 0.58503 | miRanda | -0.23 | 0.00138 | NA | |
124 | hsa-miR-361-5p | C18orf25 | -0.65 | 0 | 0.25 | 3.0E-5 | mirMAP | -0.16 | 2.0E-5 | NA | |
125 | hsa-miR-361-5p | C2CD3 | -0.65 | 0 | -0.09 | 0.17034 | miRanda | -0.15 | 0.0001 | NA | |
126 | hsa-miR-361-5p | C3orf58 | -0.65 | 0 | 0.39 | 6.0E-5 | PITA; miRNATAP | -0.14 | 0.01574 | NA | |
127 | hsa-miR-361-5p | C5orf51 | -0.65 | 0 | 0.15 | 0.01292 | miRNATAP | -0.18 | 0 | NA | |
128 | hsa-miR-361-5p | CA8 | -0.65 | 0 | 0.62 | 0.0176 | miRanda | -0.76 | 0 | NA | |
129 | hsa-miR-361-5p | CABYR | -0.65 | 0 | 0.71 | 0 | miRanda | -0.25 | 0.00203 | NA | |
130 | hsa-miR-361-5p | CACNB4 | -0.65 | 0 | 0.97 | 0 | miRanda; mirMAP | -0.43 | 2.0E-5 | NA | |
131 | hsa-miR-361-5p | CALCOCO2 | -0.65 | 0 | 0.24 | 0 | miRNAWalker2 validate; miRanda | -0.13 | 0 | NA | |
132 | hsa-miR-361-5p | CALCRL | -0.65 | 0 | 0.44 | 0.00449 | MirTarget; PITA; miRanda; miRNATAP | -0.45 | 0 | NA | |
133 | hsa-miR-361-5p | CALD1 | -0.65 | 0 | 1.23 | 0 | miRanda; miRNATAP | -0.5 | 0 | NA | |
134 | hsa-miR-361-5p | CALHM2 | -0.65 | 0 | 0.63 | 0 | miRanda | -0.14 | 0.02702 | NA | |
135 | hsa-miR-361-5p | CAMK2D | -0.65 | 0 | 0.51 | 0 | PITA; miRanda; miRNATAP | -0.24 | 1.0E-5 | NA | |
136 | hsa-miR-361-5p | CAPN6 | -0.65 | 0 | 2.48 | 0 | PITA; miRanda; miRNATAP | -0.89 | 0 | NA | |
137 | hsa-miR-361-5p | CASK | -0.65 | 0 | -0.03 | 0.61182 | mirMAP | -0.12 | 0.00015 | NA | |
138 | hsa-miR-361-5p | CASP1 | -0.65 | 0 | 0.94 | 0 | miRanda | -0.26 | 0.00441 | NA | |
139 | hsa-miR-361-5p | CASP10 | -0.65 | 0 | 0.41 | 0.00298 | miRanda | -0.23 | 0.00522 | NA | |
140 | hsa-miR-361-5p | CASP2 | -0.65 | 0 | -0.07 | 0.53424 | miRanda | -0.36 | 0 | NA | |
141 | hsa-miR-361-5p | CAT | -0.65 | 0 | 0.52 | 0 | miRanda | -0.31 | 0 | NA | |
142 | hsa-miR-361-5p | CAV1 | -0.65 | 0 | 1.75 | 0 | miRanda | -0.49 | 0 | NA | |
143 | hsa-miR-361-5p | CAV2 | -0.65 | 0 | 1.54 | 0 | miRanda | -0.47 | 0 | NA | |
144 | hsa-miR-361-5p | CBX5 | -0.65 | 0 | 0.17 | 0.00637 | mirMAP | -0.2 | 0 | NA | |
145 | hsa-miR-361-5p | CBX6 | -0.65 | 0 | 0.85 | 0 | mirMAP | -0.53 | 0 | NA | |
146 | hsa-miR-361-5p | CCDC121 | -0.65 | 0 | 0.21 | 0.00438 | miRanda | -0.22 | 0 | NA | |
147 | hsa-miR-361-5p | CCDC6 | -0.65 | 0 | -0.27 | 0.00044 | miRanda | -0.21 | 1.0E-5 | NA | |
148 | hsa-miR-361-5p | CCDC68 | -0.65 | 0 | 1.04 | 0 | miRanda | -0.35 | 0.00122 | NA | |
149 | hsa-miR-361-5p | CCDC88A | -0.65 | 0 | 1.01 | 0 | miRanda | -0.32 | 3.0E-5 | NA | |
150 | hsa-miR-361-5p | CCDC91 | -0.65 | 0 | 0.16 | 0.00908 | miRanda | -0.19 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL DEVELOPMENT | 153 | 1426 | 1.181e-12 | 1.832e-09 |
2 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 100 | 788 | 1.089e-12 | 1.832e-09 |
3 | CIRCULATORY SYSTEM DEVELOPMENT | 100 | 788 | 1.089e-12 | 1.832e-09 |
4 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 87 | 689 | 4.524e-11 | 5.263e-08 |
5 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 162 | 1656 | 3.578e-10 | 2.618e-07 |
6 | NEUROGENESIS | 142 | 1402 | 5.065e-10 | 2.618e-07 |
7 | VASCULATURE DEVELOPMENT | 65 | 469 | 3.095e-10 | 2.618e-07 |
8 | CELLULAR COMPONENT MORPHOGENESIS | 102 | 900 | 4.943e-10 | 2.618e-07 |
9 | TISSUE DEVELOPMENT | 151 | 1518 | 4.829e-10 | 2.618e-07 |
10 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 87 | 724 | 5.756e-10 | 2.678e-07 |
11 | BLOOD VESSEL MORPHOGENESIS | 54 | 364 | 8.578e-10 | 3.326e-07 |
12 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 138 | 1360 | 8.109e-10 | 3.326e-07 |
13 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 161 | 1672 | 1.301e-09 | 4.658e-07 |
14 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 169 | 1791 | 2.147e-09 | 7.135e-07 |
15 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 120 | 1152 | 2.493e-09 | 7.733e-07 |
16 | NEURON PROJECTION DEVELOPMENT | 69 | 545 | 4.373e-09 | 1.197e-06 |
17 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 138 | 1395 | 4.244e-09 | 1.197e-06 |
18 | POSITIVE REGULATION OF GENE EXPRESSION | 162 | 1733 | 9.427e-09 | 2.193e-06 |
19 | LOCOMOTION | 115 | 1114 | 9.176e-09 | 2.193e-06 |
20 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 64 | 498 | 8.956e-09 | 2.193e-06 |
21 | CELL PROJECTION ORGANIZATION | 98 | 902 | 9.93e-09 | 2.2e-06 |
22 | PROTEIN LOCALIZATION | 166 | 1805 | 1.885e-08 | 3.988e-06 |
23 | POSITIVE REGULATION OF CELL COMMUNICATION | 145 | 1532 | 2.906e-08 | 5.878e-06 |
24 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 174 | 1929 | 3.219e-08 | 5.945e-06 |
25 | NEURON DIFFERENTIATION | 94 | 874 | 3.295e-08 | 5.945e-06 |
26 | NEGATIVE REGULATION OF CELL COMMUNICATION | 119 | 1192 | 3.322e-08 | 5.945e-06 |
27 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 100 | 957 | 5.003e-08 | 8.314e-06 |
28 | INTRACELLULAR SIGNAL TRANSDUCTION | 147 | 1572 | 4.94e-08 | 8.314e-06 |
29 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 162 | 1784 | 6.709e-08 | 1.076e-05 |
30 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 124 | 1275 | 7.363e-08 | 1.142e-05 |
31 | NEURON DEVELOPMENT | 77 | 687 | 1.139e-07 | 1.71e-05 |
32 | REGULATION OF CELL DIFFERENTIATION | 139 | 1492 | 1.489e-07 | 2.166e-05 |
33 | CELL PART MORPHOGENESIS | 72 | 633 | 1.671e-07 | 2.25e-05 |
34 | PEPTIDYL AMINO ACID MODIFICATION | 89 | 841 | 1.607e-07 | 2.25e-05 |
35 | ANGIOGENESIS | 42 | 293 | 1.692e-07 | 2.25e-05 |
36 | PROTEIN PHOSPHORYLATION | 97 | 944 | 1.776e-07 | 2.296e-05 |
37 | TUBE DEVELOPMENT | 65 | 552 | 1.927e-07 | 2.423e-05 |
38 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 101 | 1004 | 2.712e-07 | 3.321e-05 |
39 | HEART DEVELOPMENT | 57 | 466 | 3.141e-07 | 3.747e-05 |
40 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 61 | 513 | 3.273e-07 | 3.807e-05 |
41 | CHONDROCYTE DIFFERENTIATION | 16 | 60 | 3.435e-07 | 3.899e-05 |
42 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 111 | 1142 | 3.863e-07 | 4.28e-05 |
43 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 139 | 1518 | 4.042e-07 | 4.374e-05 |
44 | NEURON PROJECTION MORPHOGENESIS | 51 | 402 | 4.32e-07 | 4.569e-05 |
45 | TISSUE MORPHOGENESIS | 62 | 533 | 5.639e-07 | 5.83e-05 |
46 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 100 | 1008 | 5.953e-07 | 6.021e-05 |
47 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 159 | 1805 | 6.111e-07 | 6.05e-05 |
48 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 162 | 1848 | 6.36e-07 | 6.165e-05 |
49 | REGULATION OF PROTEIN MODIFICATION PROCESS | 152 | 1710 | 6.58e-07 | 6.248e-05 |
50 | REGULATION OF DEVELOPMENTAL GROWTH | 40 | 289 | 8.334e-07 | 7.317e-05 |
51 | CELL MOTILITY | 86 | 835 | 8.24e-07 | 7.317e-05 |
52 | LOCALIZATION OF CELL | 86 | 835 | 8.24e-07 | 7.317e-05 |
53 | HEAD DEVELOPMENT | 76 | 709 | 8.065e-07 | 7.317e-05 |
54 | MORPHOGENESIS OF AN EPITHELIUM | 50 | 400 | 8.728e-07 | 7.521e-05 |
55 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 79 | 750 | 9.763e-07 | 8.26e-05 |
56 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 34 | 229 | 1.103e-06 | 8.848e-05 |
57 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 170 | 1977 | 1.095e-06 | 8.848e-05 |
58 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 127 | 1381 | 1.076e-06 | 8.848e-05 |
59 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 80 | 767 | 1.228e-06 | 9.685e-05 |
60 | REGULATION OF CELL PROJECTION ORGANIZATION | 63 | 558 | 1.278e-06 | 9.913e-05 |
61 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 88 | 872 | 1.438e-06 | 0.0001097 |
62 | REGULATION OF TRANSPORT | 157 | 1804 | 1.493e-06 | 0.0001121 |
63 | REGULATION OF CELL DEVELOPMENT | 85 | 836 | 1.616e-06 | 0.0001193 |
64 | REGULATION OF GTPASE ACTIVITY | 72 | 673 | 1.692e-06 | 0.000123 |
65 | RESPONSE TO WOUNDING | 63 | 563 | 1.727e-06 | 0.0001237 |
66 | RESPONSE TO ENDOGENOUS STIMULUS | 131 | 1450 | 1.837e-06 | 0.0001295 |
67 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 99 | 1021 | 1.892e-06 | 0.0001314 |
68 | UROGENITAL SYSTEM DEVELOPMENT | 40 | 299 | 1.995e-06 | 0.0001365 |
69 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 26 | 156 | 2.286e-06 | 0.0001542 |
70 | POSITIVE REGULATION OF GROWTH | 34 | 238 | 2.675e-06 | 0.0001778 |
71 | ESTABLISHMENT OF PROTEIN LOCALIZATION | 128 | 1423 | 3.042e-06 | 0.0001994 |
72 | POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 13 | 48 | 3.568e-06 | 0.0002274 |
73 | POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS | 13 | 48 | 3.568e-06 | 0.0002274 |
74 | REGULATION OF CELL DEATH | 131 | 1472 | 3.99e-06 | 0.0002509 |
75 | GROWTH | 49 | 410 | 4.047e-06 | 0.0002511 |
76 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 141 | 1618 | 5.083e-06 | 0.0003112 |
77 | TUBE MORPHOGENESIS | 41 | 323 | 5.654e-06 | 0.0003417 |
78 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 48 | 406 | 6.8e-06 | 0.0004015 |
79 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 39 | 303 | 6.816e-06 | 0.0004015 |
80 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 48 | 408 | 7.768e-06 | 0.0004518 |
81 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 56 | 505 | 8.453e-06 | 0.0004856 |
82 | PROTEIN CATABOLIC PROCESS | 62 | 579 | 8.622e-06 | 0.0004893 |
83 | CELLULAR RESPONSE TO STRESS | 136 | 1565 | 8.757e-06 | 0.0004909 |
84 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 89 | 926 | 8.987e-06 | 0.0004978 |
85 | WOUND HEALING | 53 | 470 | 9.12e-06 | 0.0004993 |
86 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 37 | 285 | 9.561e-06 | 0.0005173 |
87 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 79 | 799 | 1.059e-05 | 0.0005662 |
88 | HOMEOSTATIC PROCESS | 119 | 1337 | 1.135e-05 | 0.0006003 |
89 | DEVELOPMENTAL GROWTH | 41 | 333 | 1.193e-05 | 0.0006235 |
90 | POSITIVE REGULATION OF AXONOGENESIS | 15 | 69 | 1.244e-05 | 0.0006434 |
91 | FOREBRAIN DEVELOPMENT | 43 | 357 | 1.278e-05 | 0.0006533 |
92 | ESTABLISHMENT OF LOCALIZATION IN CELL | 143 | 1676 | 1.304e-05 | 0.0006598 |
93 | RESPONSE TO NITROGEN COMPOUND | 83 | 859 | 1.49e-05 | 0.0007455 |
94 | REGULATION OF CELLULAR RESPONSE TO STRESS | 70 | 691 | 1.528e-05 | 0.0007561 |
95 | DENDRITE DEVELOPMENT | 16 | 79 | 1.67e-05 | 0.0008096 |
96 | REGULATION OF NEURON DIFFERENTIATION | 59 | 554 | 1.668e-05 | 0.0008096 |
97 | RESPONSE TO ABIOTIC STIMULUS | 95 | 1024 | 1.863e-05 | 0.0008937 |
98 | PHOSPHORYLATION | 110 | 1228 | 1.887e-05 | 0.0008958 |
99 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 49 | 437 | 2.282e-05 | 0.001072 |
100 | CARTILAGE DEVELOPMENT | 23 | 147 | 2.483e-05 | 0.001144 |
101 | REGULATION OF CELLULAR LOCALIZATION | 113 | 1277 | 2.461e-05 | 0.001144 |
102 | REGULATION OF AXONOGENESIS | 25 | 168 | 2.701e-05 | 0.001232 |
103 | REGULATION OF CELL MORPHOGENESIS | 58 | 552 | 2.9e-05 | 0.00131 |
104 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 15 | 74 | 3.013e-05 | 0.001348 |
105 | REGULATION OF COENZYME METABOLIC PROCESS | 12 | 50 | 3.207e-05 | 0.001408 |
106 | REGULATION OF COFACTOR METABOLIC PROCESS | 12 | 50 | 3.207e-05 | 0.001408 |
107 | EPITHELIUM DEVELOPMENT | 88 | 945 | 3.314e-05 | 0.001433 |
108 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 85 | 905 | 3.326e-05 | 0.001433 |
109 | REGULATION OF RESPONSE TO STRESS | 126 | 1468 | 3.401e-05 | 0.001452 |
110 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 40 | 337 | 3.545e-05 | 0.001478 |
111 | REGULATION OF BODY FLUID LEVELS | 54 | 506 | 3.555e-05 | 0.001478 |
112 | POSITIVE REGULATION OF AUTOPHAGY | 15 | 75 | 3.558e-05 | 0.001478 |
113 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 18 | 102 | 3.652e-05 | 0.001504 |
114 | CELL PROLIFERATION | 67 | 672 | 3.816e-05 | 0.001557 |
115 | REGULATION OF PROTEIN LOCALIZATION | 88 | 950 | 4.017e-05 | 0.001625 |
116 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 41 | 352 | 4.399e-05 | 0.001756 |
117 | CONNECTIVE TISSUE DEVELOPMENT | 27 | 194 | 4.415e-05 | 0.001756 |
118 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 18 | 104 | 4.772e-05 | 0.001882 |
119 | DEVELOPMENTAL CELL GROWTH | 15 | 77 | 4.915e-05 | 0.001922 |
120 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 74 | 771 | 5.371e-05 | 0.002083 |
121 | ENDOMEMBRANE SYSTEM ORGANIZATION | 50 | 465 | 5.647e-05 | 0.002171 |
122 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 42 | 368 | 5.722e-05 | 0.002182 |
123 | RHYTHMIC PROCESS | 36 | 298 | 5.933e-05 | 0.002244 |
124 | CELL GROWTH | 21 | 135 | 6.008e-05 | 0.002255 |
125 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 57 | 554 | 6.087e-05 | 0.002266 |
126 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 30 | 232 | 6.945e-05 | 0.002565 |
127 | PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 81 | 873 | 7.693e-05 | 0.002818 |
128 | INSULIN RECEPTOR SIGNALING PATHWAY | 15 | 80 | 7.798e-05 | 0.002835 |
129 | REGULATION OF HYDROLASE ACTIVITY | 114 | 1327 | 7.899e-05 | 0.002849 |
130 | PEPTIDYL SERINE MODIFICATION | 22 | 148 | 8.16e-05 | 0.002921 |
131 | REGULATION OF ORGANELLE ORGANIZATION | 103 | 1178 | 9.063e-05 | 0.003219 |
132 | PROTEOLYSIS | 105 | 1208 | 9.736e-05 | 0.003432 |
133 | REGULATION OF ORGAN GROWTH | 14 | 73 | 0.0001039 | 0.003633 |
134 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 35 | 296 | 0.0001149 | 0.00399 |
135 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 19 | 121 | 0.0001166 | 0.00399 |
136 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 23 | 162 | 0.0001164 | 0.00399 |
137 | REGULATION OF CELL PROLIFERATION | 125 | 1496 | 0.0001184 | 0.004 |
138 | SINGLE ORGANISM CELLULAR LOCALIZATION | 82 | 898 | 0.0001186 | 0.004 |
139 | REGULATION OF GROWTH | 62 | 633 | 0.0001218 | 0.004076 |
140 | REGULATION OF MAPK CASCADE | 64 | 660 | 0.0001267 | 0.004212 |
141 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 88 | 983 | 0.0001339 | 0.004419 |
142 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 27 | 207 | 0.0001355 | 0.00444 |
143 | POSITIVE REGULATION OF KINASE ACTIVITY | 50 | 482 | 0.0001384 | 0.004473 |
144 | POSITIVE REGULATION OF HEART GROWTH | 8 | 27 | 0.0001375 | 0.004473 |
145 | CELLULAR MACROMOLECULE LOCALIZATION | 106 | 1234 | 0.0001421 | 0.004529 |
146 | HEMOSTASIS | 36 | 311 | 0.0001421 | 0.004529 |
147 | REGULATION OF SYNAPSE ORGANIZATION | 18 | 113 | 0.0001449 | 0.004587 |
148 | REGULATION OF HOMEOSTATIC PROCESS | 47 | 447 | 0.0001586 | 0.004985 |
149 | MESENCHYMAL CELL DIFFERENTIATION | 20 | 134 | 0.0001596 | 0.004985 |
150 | VESICLE MEDIATED TRANSPORT | 106 | 1239 | 0.0001657 | 0.005139 |
151 | REGULATION OF EPITHELIAL CELL MIGRATION | 23 | 166 | 0.0001687 | 0.0052 |
152 | ORGAN MORPHOGENESIS | 77 | 841 | 0.0001752 | 0.005327 |
153 | POSITIVE REGULATION OF TRANSPORT | 84 | 936 | 0.0001749 | 0.005327 |
154 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 18 | 115 | 0.000182 | 0.005442 |
155 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 46 | 437 | 0.0001807 | 0.005442 |
156 | WNT SIGNALING PATHWAY | 39 | 351 | 0.0001824 | 0.005442 |
157 | RESPONSE TO GROWTH FACTOR | 49 | 475 | 0.0001836 | 0.005442 |
158 | CELLULAR RESPONSE TO INSULIN STIMULUS | 21 | 146 | 0.0001883 | 0.005544 |
159 | NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 11 | 51 | 0.000191 | 0.005588 |
160 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 91 | 1036 | 0.0001994 | 0.005727 |
161 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 91 | 1036 | 0.0001994 | 0.005727 |
162 | MACROMOLECULE CATABOLIC PROCESS | 83 | 926 | 0.0001988 | 0.005727 |
163 | CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 18 | 116 | 0.0002035 | 0.005808 |
164 | MESENCHYME DEVELOPMENT | 25 | 190 | 0.0002057 | 0.005837 |
165 | ORGANELLE TRANSPORT ALONG MICROTUBULE | 12 | 60 | 0.0002113 | 0.005926 |
166 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 98 | 1135 | 0.0002114 | 0.005926 |
167 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 35 | 306 | 0.0002202 | 0.006089 |
168 | RESPONSE TO LIPID | 80 | 888 | 0.0002202 | 0.006089 |
169 | NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 7 | 22 | 0.0002211 | 0.006089 |
170 | REGULATION OF INTRACELLULAR TRANSPORT | 60 | 621 | 0.0002246 | 0.006148 |
171 | REGULATION OF NEURON APOPTOTIC PROCESS | 25 | 192 | 0.0002425 | 0.006597 |
172 | REGULATION OF AUTOPHAGY | 30 | 249 | 0.0002479 | 0.006697 |
173 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 16 | 98 | 0.000249 | 0.006697 |
174 | REGULATION OF CATABOLIC PROCESS | 68 | 731 | 0.0002651 | 0.007089 |
175 | CELLULAR RESPONSE TO PEPTIDE | 32 | 274 | 0.0002769 | 0.007363 |
176 | EXOCRINE SYSTEM DEVELOPMENT | 10 | 45 | 0.0002867 | 0.007537 |
177 | TELENCEPHALON DEVELOPMENT | 28 | 228 | 0.0002866 | 0.007537 |
178 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 73 | 801 | 0.0002939 | 0.007682 |
179 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 48 | 472 | 0.0002958 | 0.00769 |
180 | CELL CYCLE | 110 | 1316 | 0.0003029 | 0.007831 |
181 | MEMBRANE BIOGENESIS | 8 | 30 | 0.0003081 | 0.007921 |
182 | REGULATION OF CELLULAR COMPONENT SIZE | 37 | 337 | 0.0003333 | 0.008505 |
183 | POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 6 | 17 | 0.0003345 | 0.008505 |
184 | PROTEIN LOCALIZATION TO VACUOLE | 10 | 46 | 0.0003467 | 0.008721 |
185 | POSITIVE REGULATION OF ORGAN GROWTH | 9 | 38 | 0.0003459 | 0.008721 |
186 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 53 | 541 | 0.0003675 | 0.009031 |
187 | HOMEOSTASIS OF NUMBER OF CELLS | 23 | 175 | 0.0003688 | 0.009031 |
188 | REGULATION OF CYTOSKELETON ORGANIZATION | 50 | 502 | 0.0003642 | 0.009031 |
189 | PEPTIDYL TYROSINE MODIFICATION | 24 | 186 | 0.0003662 | 0.009031 |
190 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 53 | 541 | 0.0003675 | 0.009031 |
191 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 81 | 917 | 0.0003732 | 0.009092 |
192 | PROTEIN LOCALIZATION TO ORGANELLE | 54 | 556 | 0.0004007 | 0.009711 |
193 | INTERSPECIES INTERACTION BETWEEN ORGANISMS | 62 | 662 | 0.0004086 | 0.009801 |
194 | SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM | 62 | 662 | 0.0004086 | 0.009801 |
195 | CYTOSKELETON ORGANIZATION | 75 | 838 | 0.0004171 | 0.009953 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | ENZYME BINDING | 172 | 1737 | 3.495e-11 | 3.247e-08 |
2 | CHROMATIN BINDING | 57 | 435 | 2.952e-08 | 1.371e-05 |
3 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 45 | 328 | 2.257e-07 | 6.191e-05 |
4 | MACROMOLECULAR COMPLEX BINDING | 131 | 1399 | 2.666e-07 | 6.191e-05 |
5 | RIBONUCLEOTIDE BINDING | 162 | 1860 | 9.455e-07 | 0.0001464 |
6 | PROTEIN DOMAIN SPECIFIC BINDING | 69 | 624 | 8.586e-07 | 0.0001464 |
7 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 42 | 315 | 1.218e-06 | 0.0001517 |
8 | PHOSPHATASE BINDING | 27 | 162 | 1.47e-06 | 0.0001517 |
9 | TRANSCRIPTION FACTOR BINDING | 60 | 524 | 1.444e-06 | 0.0001517 |
10 | PROTEIN KINASE ACTIVITY | 69 | 640 | 2.124e-06 | 0.0001973 |
11 | PROTEIN PHOSPHATASE BINDING | 22 | 120 | 2.711e-06 | 0.0002289 |
12 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 32 | 226 | 6.296e-06 | 0.0004874 |
13 | KINASE BINDING | 64 | 606 | 9.654e-06 | 0.0006899 |
14 | REGULATORY REGION NUCLEIC ACID BINDING | 80 | 818 | 1.382e-05 | 0.0009173 |
15 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 65 | 629 | 1.649e-05 | 0.001021 |
16 | PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 20 | 116 | 1.962e-05 | 0.001072 |
17 | MOLECULAR FUNCTION REGULATOR | 119 | 1353 | 1.95e-05 | 0.001072 |
18 | KINASE ACTIVITY | 81 | 842 | 2.21e-05 | 0.00114 |
19 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 92 | 992 | 2.563e-05 | 0.001253 |
20 | PHOSPHATIDYLINOSITOL BINDING | 28 | 200 | 2.883e-05 | 0.001339 |
21 | LIPID BINDING | 66 | 657 | 3.455e-05 | 0.001459 |
22 | PHOSPHOLIPID BINDING | 42 | 360 | 3.435e-05 | 0.001459 |
23 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 37 | 303 | 3.738e-05 | 0.001479 |
24 | ADENYL NUCLEOTIDE BINDING | 129 | 1514 | 3.821e-05 | 0.001479 |
25 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 106 | 1199 | 4.602e-05 | 0.00171 |
26 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 42 | 371 | 6.889e-05 | 0.002461 |
27 | ENZYME ACTIVATOR ACTIVITY | 50 | 471 | 7.812e-05 | 0.002688 |
28 | NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 38 | 329 | 9.853e-05 | 0.00322 |
29 | IDENTICAL PROTEIN BINDING | 105 | 1209 | 0.0001005 | 0.00322 |
30 | DOUBLE STRANDED DNA BINDING | 72 | 764 | 0.0001191 | 0.003689 |
31 | UBIQUITIN LIKE PROTEIN TRANSFERASE ACTIVITY | 45 | 420 | 0.0001415 | 0.004144 |
32 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 47 | 445 | 0.0001427 | 0.004144 |
33 | SH3 DOMAIN BINDING | 18 | 116 | 0.0002035 | 0.005727 |
34 | RECEPTOR BINDING | 122 | 1476 | 0.0002233 | 0.006101 |
35 | PROTEIN TRANSPORTER ACTIVITY | 16 | 99 | 0.0002806 | 0.007448 |
36 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 14 | 81 | 0.0003262 | 0.00819 |
37 | SEQUENCE SPECIFIC DNA BINDING | 90 | 1037 | 0.0003225 | 0.00819 |
38 | CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 16 | 101 | 0.0003544 | 0.008663 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL PROJECTION | 171 | 1786 | 5.641e-10 | 3.294e-07 |
2 | CELL JUNCTION | 121 | 1151 | 1.224e-09 | 3.574e-07 |
3 | NEURON PROJECTION | 101 | 942 | 1.158e-08 | 2.254e-06 |
4 | NEURON PART | 124 | 1265 | 4.734e-08 | 6.912e-06 |
5 | SYNAPSE | 83 | 754 | 7.969e-08 | 9.308e-06 |
6 | VACUOLE | 116 | 1180 | 1.145e-07 | 1.114e-05 |
7 | CELL SUBSTRATE JUNCTION | 51 | 398 | 3.171e-07 | 2.177e-05 |
8 | CELL PROJECTION PART | 96 | 946 | 3.657e-07 | 2.177e-05 |
9 | GOLGI APPARATUS | 134 | 1445 | 3.317e-07 | 2.177e-05 |
10 | SYNAPSE PART | 69 | 610 | 3.728e-07 | 2.177e-05 |
11 | MEMBRANE REGION | 110 | 1134 | 4.831e-07 | 2.565e-05 |
12 | DENDRITE | 55 | 451 | 5.562e-07 | 2.707e-05 |
13 | POSTSYNAPSE | 48 | 378 | 9.138e-07 | 4.105e-05 |
14 | ENDOSOME | 81 | 793 | 2.39e-06 | 9.968e-05 |
15 | NEURON SPINE | 22 | 121 | 3.127e-06 | 0.0001171 |
16 | ANCHORING JUNCTION | 56 | 489 | 3.208e-06 | 0.0001171 |
17 | SOMATODENDRITIC COMPARTMENT | 69 | 650 | 3.649e-06 | 0.0001254 |
18 | VACUOLAR MEMBRANE | 63 | 587 | 6.792e-06 | 0.0002204 |
19 | CELL LEADING EDGE | 43 | 350 | 7.784e-06 | 0.0002392 |
20 | PERINUCLEAR REGION OF CYTOPLASM | 67 | 642 | 8.884e-06 | 0.0002594 |
21 | VACUOLAR PART | 71 | 694 | 9.532e-06 | 0.0002651 |
22 | FILOPODIUM | 18 | 94 | 1.149e-05 | 0.0002916 |
23 | CYTOPLASMIC REGION | 37 | 287 | 1.121e-05 | 0.0002916 |
24 | INTRACELLULAR VESICLE | 113 | 1259 | 1.324e-05 | 0.0003221 |
25 | CELL CELL JUNCTION | 45 | 383 | 1.53e-05 | 0.0003574 |
26 | PLASMA MEMBRANE REGION | 88 | 929 | 1.757e-05 | 0.0003947 |
27 | MEMBRANE MICRODOMAIN | 36 | 288 | 2.877e-05 | 0.0006222 |
28 | SITE OF POLARIZED GROWTH | 23 | 149 | 3.096e-05 | 0.0006458 |
29 | EARLY ENDOSOME MEMBRANE | 19 | 113 | 4.497e-05 | 0.0009057 |
30 | NUCLEAR ENVELOPE | 46 | 416 | 5.652e-05 | 0.0011 |
31 | MICROTUBULE CYTOSKELETON | 95 | 1068 | 9.186e-05 | 0.001692 |
32 | ACTIN BASED CELL PROJECTION | 25 | 181 | 9.444e-05 | 0.001692 |
33 | ENDOPLASMIC RETICULUM | 135 | 1631 | 9.561e-05 | 0.001692 |
34 | CYTOSKELETON | 158 | 1967 | 0.0001061 | 0.001822 |
35 | AXON | 44 | 418 | 0.0002472 | 0.004125 |
36 | CELL CORTEX | 29 | 238 | 0.0002576 | 0.004179 |
37 | LAMELLIPODIUM | 23 | 172 | 0.0002865 | 0.004521 |
38 | ORGANELLE SUBCOMPARTMENT | 35 | 311 | 0.0003001 | 0.004612 |
39 | TRANSFERASE COMPLEX | 65 | 703 | 0.0004231 | 0.006336 |
40 | ENDOSOMAL PART | 44 | 430 | 0.0004552 | 0.006646 |
41 | CELL SURFACE | 68 | 757 | 0.0006923 | 0.009862 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Ras_signaling_pathway_hsa04014 | 33 | 232 | 4.105e-06 | 0.0002135 | |
2 | Regulation_of_actin_cytoskeleton_hsa04810 | 30 | 208 | 8.378e-06 | 0.0002178 | |
3 | Adherens_junction_hsa04520 | 15 | 72 | 2.139e-05 | 0.0003707 | |
4 | MAPK_signaling_pathway_hsa04010 | 36 | 295 | 4.799e-05 | 0.0006238 | |
5 | Mitophagy_animal_hsa04137 | 13 | 65 | 0.0001164 | 0.001211 | |
6 | Sphingolipid_signaling_pathway_hsa04071 | 18 | 118 | 0.0002531 | 0.002194 | |
7 | FoxO_signaling_pathway_hsa04068 | 19 | 132 | 0.00037 | 0.002547 | |
8 | Endocytosis_hsa04144 | 29 | 244 | 0.0003918 | 0.002547 | |
9 | Focal_adhesion_hsa04510 | 24 | 199 | 0.0009742 | 0.005629 | |
10 | Rap1_signaling_pathway_hsa04015 | 24 | 206 | 0.001572 | 0.008085 | |
11 | ErbB_signaling_pathway_hsa04012 | 13 | 85 | 0.00171 | 0.008085 | |
12 | Phosphatidylinositol_signaling_system_hsa04070 | 14 | 99 | 0.002477 | 0.01073 | |
13 | cGMP_PKG_signaling_pathway_hsa04022 | 19 | 163 | 0.004569 | 0.01784 | |
14 | PI3K_Akt_signaling_pathway_hsa04151 | 34 | 352 | 0.004804 | 0.01784 | |
15 | cAMP_signaling_pathway_hsa04024 | 21 | 198 | 0.008756 | 0.03035 | |
16 | Autophagy_animal_hsa04140 | 15 | 128 | 0.01046 | 0.03399 | |
17 | TNF_signaling_pathway_hsa04668 | 13 | 108 | 0.01334 | 0.04081 | |
18 | Phospholipase_D_signaling_pathway_hsa04072 | 16 | 146 | 0.01533 | 0.04429 | |
19 | Gap_junction_hsa04540 | 11 | 88 | 0.01683 | 0.04524 | |
20 | HIF_1_signaling_pathway_hsa04066 | 12 | 100 | 0.0174 | 0.04524 | |
21 | Hippo_signaling_pathway_hsa04390 | 16 | 154 | 0.02416 | 0.05888 | |
22 | VEGF_signaling_pathway_hsa04370 | 8 | 59 | 0.02491 | 0.05888 | |
23 | TGF_beta_signaling_pathway_hsa04350 | 10 | 84 | 0.02984 | 0.06711 | |
24 | Wnt_signaling_pathway_hsa04310 | 15 | 146 | 0.03097 | 0.06711 | |
25 | Apoptosis_hsa04210 | 14 | 138 | 0.03972 | 0.08262 | |
26 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 14 | 139 | 0.04182 | 0.08363 | |
27 | p53_signaling_pathway_hsa04115 | 8 | 68 | 0.05192 | 0.09748 | |
28 | Tight_junction_hsa04530 | 16 | 170 | 0.05249 | 0.09748 | |
29 | ECM_receptor_interaction_hsa04512 | 9 | 82 | 0.05893 | 0.1048 | |
30 | AMPK_signaling_pathway_hsa04152 | 12 | 121 | 0.06217 | 0.1048 | |
31 | Hedgehog_signaling_pathway_hsa04340 | 6 | 47 | 0.06246 | 0.1048 | |
32 | Apelin_signaling_pathway_hsa04371 | 13 | 137 | 0.07128 | 0.1101 | |
33 | Cell_cycle_hsa04110 | 12 | 124 | 0.07202 | 0.1101 | |
34 | Oocyte_meiosis_hsa04114 | 12 | 124 | 0.07202 | 0.1101 | |
35 | Hippo_signaling_pathway_multiple_species_hsa04392 | 4 | 29 | 0.09497 | 0.1411 | |
36 | mTOR_signaling_pathway_hsa04150 | 13 | 151 | 0.1261 | 0.1821 | |
37 | Necroptosis_hsa04217 | 13 | 164 | 0.1934 | 0.2717 | |
38 | Calcium_signaling_pathway_hsa04020 | 14 | 182 | 0.2121 | 0.2903 | |
39 | Cellular_senescence_hsa04218 | 12 | 160 | 0.2613 | 0.3485 | |
40 | Jak_STAT_signaling_pathway_hsa04630 | 12 | 162 | 0.2751 | 0.3576 | |
41 | Autophagy_other_hsa04136 | 3 | 32 | 0.3049 | 0.3867 | |
42 | Lysosome_hsa04142 | 9 | 123 | 0.3264 | 0.399 | |
43 | Notch_signaling_pathway_hsa04330 | 4 | 48 | 0.3299 | 0.399 | |
44 | NF_kappa_B_signaling_pathway_hsa04064 | 7 | 95 | 0.351 | 0.4148 | |
45 | Peroxisome_hsa04146 | 6 | 83 | 0.3871 | 0.4473 | |
46 | Phagosome_hsa04145 | 10 | 152 | 0.4382 | 0.4851 | |
47 | Ferroptosis_hsa04216 | 3 | 40 | 0.4385 | 0.4851 | |
48 | ABC_transporters_hsa02010 | 3 | 45 | 0.517 | 0.5601 | |
49 | Cytokine_cytokine_receptor_interaction_hsa04060 | 16 | 270 | 0.5697 | 0.6046 | |
50 | Apoptosis_multiple_species_hsa04215 | 2 | 33 | 0.6012 | 0.6253 | |
51 | Cell_adhesion_molecules_.CAMs._hsa04514 | 8 | 145 | 0.6555 | 0.6683 | |
52 | Neuroactive_ligand_receptor_interaction_hsa04080 | 15 | 278 | 0.7122 | 0.7122 |